Spyre Therapeutics Inc (NAS:SYRE)
$ 90.39 -3.25 (-3.47%) Market Cap: 7.97 Bil Enterprise Value: 6.97 Bil PE Ratio: 0 PB Ratio: 8.34 GF Score: 26/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1